Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiao'er Biantong Granules is a Traditional Chinese Medicine (TCM) formulation developed by Nanjing Shenqu Pharmaceutical Technology Service Co., Ltd. for the treatment of pediatric functional constipation and food retention syndrome. The drug is designed to regulate gastrointestinal function, promote digestion, and alleviate constipation by moistening the intestines and stimulating bowel movements. It has been evaluated in Phase II and Phase III clinical trials in China, specifically targeting pediatric populations to address chronic functional constipation and associated digestive symptoms. As a new TCM drug candidate, it represents a standardized approach to traditional herbal therapy for common pediatric gastrointestinal disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiao'er Biantong Granules.